These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1689995)

  • 1. Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus.
    Coe NE; Mengeling WL
    Arch Virol; 1990; 110(1-2):137-42. PubMed ID: 1689995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50.
    Wathen MW; Wathen LM
    J Virol; 1984 Jul; 51(1):57-62. PubMed ID: 6202885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies.
    Eloit M; Fargeaud D; L'Haridon R; Toma B
    Arch Virol; 1988; 99(1-2):45-56. PubMed ID: 2833202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and mapping of a nonessential pseudorabies virus glycoprotein.
    Wathen MW; Wathen LM
    J Virol; 1986 Apr; 58(1):173-8. PubMed ID: 3005646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies.
    Ben-Porat T; DeMarchi JM; Lomniczi B; Kaplan AS
    Virology; 1986 Oct; 154(2):325-34. PubMed ID: 2429441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of complement-independent neutralizing epitopes on pseudorabies virus glycoprotein gp50.
    Tsuda T; Yamada S; Murakami Y; Sugimura T
    J Vet Med Sci; 1991 Jun; 53(3):533-5. PubMed ID: 1715760
    [No Abstract]   [Full Text] [Related]  

  • 7. Aujeszky's disease ELISA using baculovirus expressed glycoproteins.
    Banks M
    Acta Vet Hung; 1994; 42(2-3):359-67. PubMed ID: 7810431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
    Mengeling WL; Brockmeier SL; Lager KM
    Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine.
    Eloit M; Gilardi-Hebenstreit P; Toma B; Perricaudet M
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2425-31. PubMed ID: 2172456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope analysis of glycoprotein I of pseudorabies virus.
    Jacobs L; Meloen RH; Gielkens AL; Van Oirschot JT
    J Gen Virol; 1990 Apr; 71 ( Pt 4)():881-7. PubMed ID: 1691269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without N-linked glycosylation.
    Petrovskis EA; Timmins JG; Armentrout MA; Marchioli CC; Yancey RJ; Post LE
    J Virol; 1986 Aug; 59(2):216-23. PubMed ID: 3016293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of several pseudorabies viral strains by virus-neutralization test using monoclonal antibodies.
    Nosetto EO; Echeverria MG; Horimoto T; Pecoraro MR; Galosi CM; Tohya Y; Norimine J; Takahashi E; Etcheverrigaray ME; Mikami T
    Viral Immunol; 1997; 10(3):159-64. PubMed ID: 9344338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of antigenic sites on pseudorabies virus glycoprotein gp50 implicated in virus penetration of the host cell.
    Eloit M; Bouzghaia H; Toma B
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2179-83. PubMed ID: 1698927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes.
    Fuchs W; Rziha HJ; Lukàcs N; Braunschweiger I; Visser N; Lütticken D; Schreurs CS; Thiel HJ; Mettenleiter TC
    J Gen Virol; 1990 May; 71 ( Pt 5)():1141-51. PubMed ID: 1693164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.
    Fallahi F; Wandeler AI; Nadin-Davis SA
    Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early interactions of pseudorabies virus with host cells: functions of glycoprotein gIII.
    Zuckermann F; Zsak L; Reilly L; Sugg N; Ben-Porat T
    J Virol; 1989 Aug; 63(8):3323-9. PubMed ID: 2545907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking ELISA to distinguish pseudorabies virus-infected pigs from those vaccinated with a glycoprotein gIII deletion mutant.
    Kit S; Awaya Y; Otsuka H; Kit M
    J Vet Diagn Invest; 1990 Jan; 2(1):14-23. PubMed ID: 1965296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective immunity and neutralizing antibodies to pseudorabies virus by immunization of anti-idiotypic antibodies.
    Tsuda T; Onodera T; Sugimura T; Murakami Y
    Arch Virol; 1992; 124(3-4):291-300. PubMed ID: 1318708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a competitive double antibody lateral flow assay for the detection of antibodies specific to glycoprotein B of Aujeszky's disease virus in swine sera.
    Vrublevskaya VV; Afanasyev VN; Grinevich AA; Skarga YY; Gladyshev PP; Ibragimova SA; Krylsky DV; Morenkov OS
    J Virol Methods; 2017 Feb; 240():54-62. PubMed ID: 27894861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological and functional analysis of epitopes on the S(E2) and HE(E3) glycoproteins of bovine enteric coronavirus.
    Vautherot JF; Madelaine MF; Laporte J
    Adv Exp Med Biol; 1990; 276():173-9. PubMed ID: 1715659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.